Page last updated: 2024-11-06

plumieride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

plumieride: RN refers to (1S-(1alpha,4aalpha,7alpha(R*),7aalpha))-isomer; from Allamanda cathartica & Himatanthus fallax; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Himatanthusgenus[no description available]ApocynaceaeThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH]
Allamandagenus[no description available]ApocynaceaeThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH]
Allamanda catharticaspecies[no description available]ApocynaceaeThe dogbane family of the order Gentianales. Members of the family have milky, often poisonous juice, smooth-margined leaves, and flowers in clusters.[MeSH]

Cross-References

ID SourceID
PubMed CID72319
CHEMBL ID464470
CHEBI ID8275
SCHEMBL ID419720
MeSH IDM0285505

Synonyms (26)

Synonym
agoniadin
methyl (1s,4as,7r,7as)-4'-[(1s)-1-hydroxyethyl]-5'-oxo-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-spiro[4a,7a-dihydro-1h-cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
plumieride
C09797
511-89-7
AC1L2HUJ ,
methyl (1s,4as,7r,7as)-4'-[(1s)-1-hydroxyethyl]-5'-oxo-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[4a,7a-dihydro-1h-cyclopenta[c]pyran-7,2'-furan]-4-carboxylate
CHEMBL464470
chebi:8275 ,
AC1Q6BJ5 ,
spiro(cyclopenta(c)pyran-7(1h),2'(5'h)-furan)-4-carboxylic acid, 1-(beta-d-glucopyranosyloxy)-4a,7a-dihydro-4-(1-hydroxyethyl)-5'-oxo-, methyl ester, (1s-(1alpha,4aalpha,7alpha(r*),7aalpha))-
71a048xw8v ,
nsc 609065
unii-71a048xw8v
SCHEMBL419720
plumieride [mi]
(1s,2r,4as,7as)-1-(.beta.-d-glucopyranosyloxy)-4a,7a-dihydro-4-((1s)-1-hydroxyethyl)-5-oxospiro(cyclopenta(c)pyran-7(1h),2(5h)-furan)-4-carboxylic acid methyl ester
spiro(cyclopenta(c)pyran-7(1h),2'(5'h)-furan)-4-carboxylic acid, 1-(.beta.-d-glucopyranosyloxy)-4a,7a-dihydro-4'-((1s)-1-hydroxyethyl)-5'-oxo-, methyl ester, (1s,2'r,4as,7as)-
surecn419720
DTXSID40199109
bdbm50480285
plumieride, >=95% (lc/ms-elsd)
NCGC00347624-02
AKOS032948813
FS-9946
Q27108027

Research Excerpts

Effects

ExcerptReferenceRelevance
"Plumieride has been isolated as an active principle of the leaves of Allamanda cathartica. "( Plumieride from Allamanda cathartica as an antidermatophytic agent.
Dubey, NK; Pandey, VB; Tiwari, TN, 2002
)
3.2

Treatment

ExcerptReferenceRelevance
"Plumieride treatment resulted in an arrest of spermatogenesis without any systemic side effect."( Effects of plumieride, an iridoid on spermatogenesis in male albino rats.
Bhatnager, AK; Gupta, RS; Joshi, YC; Sharma, A; Sharma, R, 2004
)
1.43

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
glycosideA glycosyl compound resulting from the attachment of a glycosyl group to a non-acyl group RO-, RS-, RSe-, etc. The bond between the glycosyl group and the non-acyl group is called a glycosidic bond. By extension, the terms N-glycosides and C-glycosides are used as class names for glycosylamines and for compounds having a glycosyl group attached to a hydrocarbyl group respectively. These terms are misnomers and should not be used. The preferred terms are glycosylamines and C-glycosyl compounds, respectively.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID336526Cytotoxicity against human lung cancer cells
AID336523Cytotoxicity against human HT1080 cells
AID336524Cytotoxicity against human melanoma cells
AID336529Cytotoxicity against mouse P388 cells
AID336528Cytotoxicity against human KB cells
AID336527Cytotoxicity against human colon cancer cells
AID397122Inhibition of HIV1 RT
AID336525Cytotoxicity against human breast cancer cells
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's3 (25.00)29.6817
2010's5 (41.67)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.64 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]